DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: The recommended testing strategy to confirm the diagnosis of a dystrophinopathy in a male patient typically begins with deletion/duplication analysis of the DMD gene, followed by DMD sequencing if negative (Birnkrant et al., 2018).